CHATSWORTH, Calif.--(BUSINESS WIRE)--CHAD Therapeutics, Inc. (AMEX:CTU) today announced the completion of a $3,500,000 financing package with a private investor that provides funding for the development and commercial roll-out of the Company’s initial products for the sleep disorder market and enhances the Company’s working capital.
